Search research articles
Contact Us
Filters
Showing results (11-20 of 43) with videos related to
Page
of 5
Sort By:
BMC Family Practice
|
June 25, 2021
Benchmarking of provider competencies and current training for prevention and management of obesity among family medicine residency programs: a cross-sectional survey
Manuela Orjuela-Grimm, W Scott Butsch, Silvia Bhatt-Carreño, et al.
Teaching and Learning in Medicine
|
December 30, 2016
Obesity Coverage on Medical Licensing Examinations in the United States. What Is Being Tested?
Robert F Kushner, W Scott Butsch, Scott Kahan, et al.
JAMA Network Open
|
September 13, 2024
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R Pfoh, Rebecca Schulte, et al.
International Journal of Laboratory Hematology
|
October 20, 2021
A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery
Frido K Bruehl, David S Bosler, W Scott Butsch, et al.
Obesity Science & Practice
|
August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility models
Timothy A Howell, Louis S Matza, Usha G Mallya, et al.
International Journal of Obesity (2005)
|
September 28, 2023
Obesity preclinical elective: a qualitative thematic analysis of student feedback
Amber Olson, Katherine Lyons, Rosanna Watowicz, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
September 19, 2024
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity
Jeffrey I Mechanick, W Scott Butsch, Sandra M Christensen, et al.
Journal of Clinical & Translational Endocrinology
|
October 10, 2024
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
Arunkumar Krishnan, Carolin V Schneider, Hendrik-Tobias Arkenau, et al.
Obesity (Silver Spring, Md.)
|
June 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status
Hamlet Gasoyan, W Scott Butsch, Rebecca Schulte, et al.
Obesity (Silver Spring, Md.)
|
October 3, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
Hamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 43) with videos related to
Sort By:
Page
of 5
BMC Family Practice
|
June 25, 2021
Benchmarking of provider competencies and current training for prevention and management of obesity among family medicine residency programs: a cross-sectional survey
Manuela Orjuela-Grimm, W Scott Butsch, Silvia Bhatt-Carreño, et al.
Teaching and Learning in Medicine
|
December 30, 2016
Obesity Coverage on Medical Licensing Examinations in the United States. What Is Being Tested?
Robert F Kushner, W Scott Butsch, Scott Kahan, et al.
JAMA Network Open
|
September 13, 2024
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R Pfoh, Rebecca Schulte, et al.
International Journal of Laboratory Hematology
|
October 20, 2021
A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery
Frido K Bruehl, David S Bosler, W Scott Butsch, et al.
Obesity Science & Practice
|
August 7, 2023
Health state utilities associated with hyperphagia: Data for use in cost-utility models
Timothy A Howell, Louis S Matza, Usha G Mallya, et al.
International Journal of Obesity (2005)
|
September 28, 2023
Obesity preclinical elective: a qualitative thematic analysis of student feedback
Amber Olson, Katherine Lyons, Rosanna Watowicz, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
September 19, 2024
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity
Jeffrey I Mechanick, W Scott Butsch, Sandra M Christensen, et al.
Journal of Clinical & Translational Endocrinology
|
October 10, 2024
Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
Arunkumar Krishnan, Carolin V Schneider, Hendrik-Tobias Arkenau, et al.
Obesity (Silver Spring, Md.)
|
June 10, 2025
Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status
Hamlet Gasoyan, W Scott Butsch, Rebecca Schulte, et al.
Obesity (Silver Spring, Md.)
|
October 3, 2025
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
Hamlet Gasoyan, W Scott Butsch, Nicholas J Casacchia, et al.
Page
of 5